Paper3350837
Role of recombinant interferon alpha 2 and cimetidine in patients with advanced malignant melanoma.
Mughal TI and 3 others. J Cancer Res Clin Oncol, 1988. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Role of recombinant interferon alpha 2 and cimetidine in patients with advanced malignant melanoma. Papers, record 3350837. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3350837
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Cimetidine | Major topic |
| Interferon Type I | Major topic |
| Melanoma | Major topic |
| Female | |
| Male | |
| Recombinant Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RR-51 | NCRR NIH HHS | United States | PubMed |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7459811 | Reporting results of cancer treatment. | Cancer | 1981 | https://conductscience.org/library/papers/7459811 | PubMed |
| 2 | 6663321 | Immunological effects of recombinant interferon-alpha 2 in cancer patients. | J Biol Response Mod | 1983 | https://conductscience.org/library/papers/6663321 | PubMed |
| 3 | 6176159 | Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients. | Ann Intern Med | 1982 | https://conductscience.org/library/papers/6176159 | PubMed |
| 4 | 7121522 | Human leukocyte interferon and cimetidine for metastatic melanoma. | N Engl J Med | 1982 | https://conductscience.org/library/papers/7121522 | PubMed |
| 5 | 86136 | Antitumour effect of cimetidine. | Lancet | 1979 | https://conductscience.org/library/papers/86136 | PubMed |
| 6 | 26297790 | Pillars Article: Virus Interference. I. The Interferon. Proc R Soc Lond B Biol Sci. 1957. 147: 258-267. | J Immunol | 2015 | https://conductscience.org/library/papers/26297790 | PubMed |
| 7 | 6174742 | Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. | JAMA | 1982 | https://conductscience.org/library/papers/6174742 | PubMed |
| 8 | 6110864 | Successful tumour immunotherapy with cimetidine in mice. | Lancet | 1981 | https://conductscience.org/library/papers/6110864 | PubMed |
| 9 | 3804370 | Treatment of metastatic malignant melanoma with recombinant interferon alpha 2. | Immunobiology | 1986 | https://conductscience.org/library/papers/3804370 | PubMed |
| 10 | 6323641 | Interferons in the treatment of human cancer. | J Clin Oncol | 1984 | https://conductscience.org/library/papers/6323641 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39850890 | Extracellular matrix shapes cancer stem cell behavior in breast cancer: a mini review. | Front Immunol | 2024 | https://conductscience.org/library/papers/39850890 | PubMed |
| 9306593 | Anorectal malignant melanoma: report of a case. | Surg Today | 1997 | https://conductscience.org/library/papers/9306593 | PubMed |
| 8542245 | Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma. | Med Oncol | 1995 | https://conductscience.org/library/papers/8542245 | PubMed |
| 8097142 | Effects of histamine type-2 receptor antagonists on indomethacin and IL-2 immunotherapy of metastasis. | Clin Exp Metastasis | 1993 | https://conductscience.org/library/papers/8097142 | PubMed |
| 7681371 | Interferon-alpha in malignant and viral diseases. A review. | Drugs | 1993 | https://conductscience.org/library/papers/7681371 | PubMed |
| 2573506 | Rational use of antihistamines in allergic dermatological conditions. | Drugs | 1989 | https://conductscience.org/library/papers/2573506 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3350837
GET https://conductscience.org/api/papers/v1/3350837/authors